Back to
FIL Ltd
AXSM
9 quarters
Position history for
FIL Ltd's holdings in Axsome Therapeutics, Inc.
No. FIL exited its AXSM (Axsome Therapeutics) position in Q3 2021. Its Q2 2021 13F listed 10,176 shares worth $686,000. FIL first reported AXSM in Q3 2019 and held it in 8 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$4.3M
Total Shares Change
-210,253
Quarter-by-Quarter History
Other major holders of AXSM: Vanguard Group Inc., BlackRock, Inc.